Low frequency of primary lipid screening among Medicare patients with rheumatoid arthritis
Open Access
- 18 January 2011
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 63 (5), 1221-1230
- https://doi.org/10.1002/art.30239
Abstract
Objective Although studies have demonstrated suboptimal preventive care in RA patients, performance of primary lipid screening (i.e., testing before cardiovascular disease [CVD], CVD risk equivalents, or hyperlipidemia is evident) has not been systematically examined. The purpose of this study was to examine associations between primary lipid screening and visits to primary care providers (PCPs) and rheumatologists among a national sample of older RA patients. Methods This retrospective cohort study examined a 5% Medicare sample that included 3,298 RA patients without baseline CVD, diabetes mellitus, or hyperlipidemia, who were considered eligible for primary lipid screening during the years 2004–2006. The outcome was probability of lipid screening by the relative frequency of primary care and rheumatology visits, or seeing a PCP at least once each year. Results Primary lipid screening was performed in only 45% of RA patients. Overall, 65% of patients received both primary and rheumatology care, and 50% saw a rheumatologist as often as a PCP. Any primary care predicted more lipid screening than lone rheumatology care (26% [95% confidence interval (95% CI) 21–32]). As long as a PCP was involved, performance of lipid screening was similar regardless of the balance between primary and rheumatology visits (44–48% [95% CI 41–51]). Not seeing a PCP at least annually decreased screening by 22% (adjusted risk ratio 0.78 [95% CI 0.71–0.84]). Conclusion Primary lipid screening was performed in fewer than half of eligible RA patients, highlighting a key target for CVD risk reduction efforts. Annual visits to a PCP improved lipid screening, although performance remained poor (51%). Half of RA patients saw their rheumatologist as often or more often than they saw a PCP, illustrating the need to study optimal partnerships between PCPs and rheumatologists for screening patients for CVD risks.Keywords
This publication has 46 references indexed in Scilit:
- Lipids, myocardial infarction and ischaemic stroke in patients with rheumatoid arthritis in the Apolipoprotein-related Mortality RISk (AMORIS) StudyAnnals Of The Rheumatic Diseases, 2010
- Excess mortality emerges after 10 years in an inception cohort of early rheumatoid arthritisArthritis Care & Research, 2010
- EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritisAnnals Of The Rheumatic Diseases, 2009
- Explaining the Decrease in U.S. Deaths from Coronary Disease, 1980–2000The New England Journal of Medicine, 2007
- Trends in prevention of glucocorticoid-induced osteoporosis2006
- Delivery of Preventive Services to Older Adults by Primary Care PhysiciansJAMA, 2005
- Identifying Hypertension-Related Comorbidities From Administrative Data: What's the Optimal Approach?American Journal of Medical Quality, 2004
- Risk Adjustment of Medicare Capitation Payments Using the CMS-HCC Model2004
- The Treatment of Unrelated Disorders in Patients with Chronic Medical DiseasesThe New England Journal of Medicine, 1998
- Sensitivity and positive predictive value of medicare part B physician claims for rheumatologic diagnoses and proceduresArthritis & Rheumatism, 1997